| Drug Name |
Oxaliplatin |
| Drug ID |
BADD_D01633 |
| Description |
Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. Oxaliplatin is marketed by Sanofi-Aventis under the trademark Eloxatin®. |
| Indications and Usage |
Used in combination with infusional 5-FU/LV, is indicated for the treatment of advanced carcinoma of the colon or rectum and for adjuvant treatment of stage III colon cancer patients who have undergone complete resection of the primary tumor. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
L01XA03 |
| DrugBank ID |
DB00526
|
| KEGG ID |
D01790
|
| MeSH ID |
D000077150
|
| PubChem ID |
9887053
|
| TTD Drug ID |
D0Y3ME
|
| NDC Product Code |
0781-9317; 50742-406; 50742-405; 72266-125; 16729-332; 68083-171; 72603-301; 72659-865; 45963-611; 0781-3315; 72266-126; 67184-0007; 60505-6132; 0781-3317; 49812-0075; 67184-0508; 67184-0502; 0955-1725; 67184-0510; 67457-469; 69097-274; 0781-9315; 71288-101; 0703-3985; 68083-314; 0955-1731; 68083-170; 14778-0404; 72603-101; 55150-331; 63592-0700; 79672-826; 54875-0006; 63759-7004; 63323-750; 25021-233; 68083-177; 0955-1733; 68001-468; 61703-363; 43066-014; 57884-0017; 67184-0501; 55150-332; 69097-353; 67457-442; 0703-3986; 71288-149; 53104-7649; 79672-825; 13808-502; 67184-0509; 72266-162; 68083-176; 72266-161; 0955-1727; 68554-0083; 43066-018 |
| Synonyms |
Oxaliplatin | Oxalato-(1,2-cyclohexanediamine)platinum II | Oxaliplatin, (SP-4-2-(1R-trans))-isomer | L-OHP Cpd | Platinum(II)-1,2-cyclohexanediamine Oxalate | 1,2-Diaminocyclohexane Platinum Oxalate | 1,2 Diaminocyclohexane Platinum Oxalate | 1,2-Diamminocyclohexane(trans-1)oxolatoplatinum(II) | Platinum(2+) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1) | Oxaliplatine | Eloxatine | Eloxatin | Oxaliplatin, (SP-4-3-(cis))-isomer | ACT 078 | ACT-078 | ACT078 | Cis-oxalato-(trans-l)-1,2-diaminocyclohexane-platinum(II) | Oxaliplatin, (SP-4-2-(1S-trans))-isomer |
